Redox state and methods to evaluate oxidative stress in liver damage: From bench to bedside
Journal Title: Annals of Hepatology - Year 2016, Vol 15, Issue 2
Abstract
Oxidative stress is importantly involved in the pathophysiology of various liver diseases. The redox state participates on the courseof the inflammatory, metabolic and proliferative liver diseases. The main sources of the reactive oxygen species (ROS) are represented by the mitochondria and cytochrome P450 enzymes in the hepatocyte, Kupffer cells and neutrophils. Cells are provided with efficient molecular strategies to strictly control the intracellular ROS level and to maintain the balance between oxidant and antioxidant molecules. Hepatocyte’s proteins, lipids and DNA are among the cellular structures to be affected primarily by ROS and reactive nitrogen species (RNS). This process disrupts at cellular and molecular level the structure-function relationship on liver cells at different sites. Therefore, further studies on the molecular mechanisms of the oxidative stress pathways on liver diseases are urgently required, because they could explain the pathogenesis of various liver disorders. Moreover, new methods to evaluate oxidative stress like the oxidative markers among hepatocytes offers the potential to diagnose the degree of liver injury and ultimately to assess theresponse to pharmacological therapies. In this review, we discuss the molecular, metabolic and aging aspects of the oxidativestress, and the methods to evaluate oxidative stress on liver damage.
Authors and Affiliations
Jonathan Arauz, Erika Ramos-Tovar, Pablo Muriel
Keywords
Related Articles
- EP ID EP78552
- DOI -
- Views 159
- Downloads 0
Annual Meeting of the Mexican Association pf Hepatology
Changes in insulin sensitivity and body weight during and after peginterferon and ribavirin therapy for hepatitis C
Serum concentrations of substance P in cholestasis
Substance P (SP) is an excitatory neuropeptide that acts via the neurokinin-1 receptor (NK-1) in the nervous system. Pruritus, a complication of cholestasis, is a nociceptive stimulus; thus, we hypothesized that cholesta...
Liver iron concentration is not raised in patients with dysmetabolic hyperferritinemia
Background & aims. Hyperferritinemia (HF) is frequently present in patients with metabolic syndrome (MS). MS associated with HF is named dysmetabolic hyperferritinemia (DH). There are some publications that p...
Albumin dialysis with molecular adsorbent recirculating system (MARS) for the treatment of hepatic encephalopathy in liver failure
Acute, acute-on-chronic and chronic liver diseases are major health issues worldwide, and most cases end with the need for liver transplantation. Up to 90% of the patients die waiting for an organ to be transplanted. Hep...